Biocartis Group NV: Disclosure of outstanding voting securities

    NEXT STORY
    EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437 in Anterior Uveitis
    PREV STORY
    Project HOPE and Partners Train the Humanitarian Workforce for the Next Disaster
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019

    author_avatar
    NASDAQ Market News

    RadioMedix Selected for National Cancer Institute’s Investor Initiatives and Presentation at BIO Investor Forum

    Houston TX, Oct. 17, 2017 (GLOBE NEWSWIRE) -- Houston, TX--RadioMedix Inc. a clinical-stage company, ...

    author_avatar
    NASDAQ Market News

    Give an Hour Mental Health Professionals to Offer No-Cost Counseling Services to Victims, Families, and First Responders of Orlando Shooting

    WASHINGTON, June 13, 2016 (GLOBE NEWSWIRE) -- Give an Hour™ (www.giveanhour.org), a national nonprofit ...

    author_avatar
    NASDAQ Market News